Article
The Psychiatric Genomics Consortium: discoveries and directions.
The lancet. Psychiatry - 1 Aug 2025
Agrawal Arpana, Bulik Cynthia M, Abebe Dawit Shawel, Andreassen Ole A, Atkinson Elizabeth G, Choi Karmel W, Corvin Aiden, Davies Helena L, Davis Lea K, Docherty Anna R, Edenberg Howard J, Franke Barbara, Gelernter Joel, Giusti-Rodríguez Paola, Hettema John M, Hjerling-Leffler Jens, Huang Hailiang, Johnson Emma C, Lewis Cathryn M, Lu Yi, Lynall Mary-Ellen, Martin Joanna, McIntosh Andrew M, Montalvo-Ortiz Janitza L, Mullins Niamh, Nievergelt Caroline M, O'Connell Kevin S, O'Donovan Michael C, Okewole Adeniran, Peterson Roseann E, Posthuma Danielle, Sebat Jonathan, Smoller Jordan W, Sud Reeteka, Viswanath Biju, Walters James T R, Won Hyejung, Wray Naomi R, Sullivan Patrick F
Abstract excerpt
Research by the Psychiatric Genomics Consortium (PGC) has advanced the discovery of common and rare genetic variations that contribute to the susceptibility to many psychiatric disorders and neurodevelopmental conditions. This Review reflects on major findings from the past 5 years of research by the PGC in five priority areas: discovery of common variants using genome-wide association studies; rare variation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.